13-Valent pneumococcal conjugate vaccines vaccination innovative strategy in Weifang City,China:a case study  

作　　者：Jiachen Wang Yujue Wang Ruoyu Xu Ting Zhang Yanyan Jiang Yuanyuan Wang Yi Wang Yuanze Du Wenxue Sun Kai Deng Weizhong Yang Zengwu Wang Luzhao Feng Chunping Wang 

机构地区：[1]不详

出　　处：《Infectious Diseases of Poverty》2023年第6期108-108,共1页贫困所致传染病（英文）

基　　金：supported by Bill and Melinda Gates Foundation(OPP1216666);Natural Science Foundation of Shandong Province(ZR2022MG032);Key R&D Program of Shandong Province,China(2023RKY07003);the research“Innovation Lab of Vaccine Delivery Research,”supported by the Bill&Melinda Gates Foundation(INV034554).

摘　　要：The World Health Organization(WHO)prioritizes pneumococcal disease as a vaccine-preventable disease and recommends the inclusion of pneumococcal conjugate vaccines(PCV)in national immunization programs worldwide.However,PCV is not included in the National Immunization Program in China and has low vaccination coverage due to its high cost.To address this,Weifang City implemented an innovative strategy for a 13-valent PCV(PCV13)on June 1,2021.This strategy aimed to provide one dose of PCV13 free of charge for children aged 6 months to 2 years in registered households and to adopt a commercial insurance model with one dose of PCV13 free of charge in 2023 for children over 2 years old.The Health Commission of Weifang and other departments conducted a comprehensive investigation and considered various factors,such as vaccine efectiveness,safety,accessibility,vaccine price,and immunization schedules,for eligible children(under 5 years old).Stakeholder opinions were also solicited before implementing the policy.The Commission negotiated with various vaccine manufacturers to maximize its negotiating power and reduce vaccine prices.The implementation plan was introduced under the Healthy Weifang Strategy.Following the implementation of this strategy,the full course of vaccination coverage increased signifcantly from 0.67 to 6.59%.However,vaccination coverage is still lower than that in developed countries.Weifang’s PCV13 vaccination innovative strategy is the frst of its kind in Chinese mainland and is an active pilot of non-immunization program vaccination strategies.To further promote PCV13 vaccination,Weifang City should continue to implement this strategy and explore appropriate fnancing channels.Regions with higher levels of economic development can innovate the implementation of vaccine programs,broaden fnancing channels,improve accessibility to vaccination services,and advocate for more localities to incorporate PCV13 into locally expanded immunization programs or people-benefting projects.A monitoring and evalua

关 键 词：Pneumococcal conjugate vaccine Pneumococcal disease Non-immunization program VACCINATION Vaccine-preventable disease Vaccination strategy China 

分 类 号：R186[医药卫生—流行病学]